TECENTRIQ Presentation
TECENTRIQ: First FDA–Approved Adjuvant Cancer Immunotherapy for Stage II to III APD-L1+NSCLC FEATURED FACULTY Eric Nadler, MD RSVP: Angie Horn Redmann at (650) 580-8821 |
|
TECENTRIQ: First FDA–Approved Adjuvant Cancer Immunotherapy for Stage II to III APD-L1+NSCLC FEATURED FACULTY Eric Nadler, MD RSVP: Angie Horn Redmann at (650) 580-8821 |
|